82 related articles for article (PubMed ID: 29606341)
1. Myeloid-derived suppressors cells (MDSC) correlate with clinicopathologic factors and pathologic complete response (pCR) in patients with urothelial carcinoma (UC) undergoing cystectomy.
Ornstein MC; Diaz-Montero CM; Rayman P; Elson P; Haywood S; Finke JH; Kim JS; Pavicic PG; Lamenza M; Devonshire S; Dann P; Schach K; Stephenson A; Campbell S; Emamekhoo H; Ernstoff MS; Hoimes CJ; Gilligan TD; Rini BI; Garcia JA; Grivas P
Urol Oncol; 2018 Sep; 36(9):405-412. PubMed ID: 29606341
[TBL] [Abstract][Full Text] [Related]
2. Myeloid derived suppressor cells in peripheral blood can be a prognostic factor in canine transitional cell carcinoma.
Yokota S; Yonezawa T; Momoi Y; Maeda S
Vet Immunol Immunopathol; 2024 Mar; 269():110716. PubMed ID: 38308864
[TBL] [Abstract][Full Text] [Related]
3. Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer.
Idorn M; Køllgaard T; Kongsted P; Sengeløv L; Thor Straten P
Cancer Immunol Immunother; 2014 Nov; 63(11):1177-87. PubMed ID: 25085000
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer.
de Goeje PL; Bezemer K; Heuvers ME; Dingemans AC; Groen HJ; Smit EF; Hoogsteden HC; Hendriks RW; Aerts JG; Hegmans JP
Oncoimmunology; 2015 Jul; 4(7):e1014242. PubMed ID: 26140237
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic Analysis of Circulating Myeloid Derived Suppressor Cells and Their Subpopulations in Egyptian Females with Breast Cancer: A Single-Centre Case-Control Study.
Saed SM; Abbas S; El Ansary MS; Abdelfattah W; Maurice KK; Mohamed ME; Tawfik Koptan DM
Asian Pac J Cancer Prev; 2024 Jan; 25(1):257-263. PubMed ID: 38285792
[TBL] [Abstract][Full Text] [Related]
6. Decreased programmed cell death ligand 2-positive monocytic myeloid-derived suppressor cells and programmed cell death protein 1-positive T-regulatory cells in patients with type 2 diabetes: implications for immunopathogenesis.
Liu Z; Zhang M; Shi X; Zhao W; Cao C; Jin L; Wang Y; Xiao J
Endocr Connect; 2023 Aug; 12(9):. PubMed ID: 37410080
[TBL] [Abstract][Full Text] [Related]
7. Myeloid derived suppressor cells in human diseases.
Greten TF; Manns MP; Korangy F
Int Immunopharmacol; 2011 Jul; 11(7):802-7. PubMed ID: 21237299
[TBL] [Abstract][Full Text] [Related]
8. Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma.
Gaißler A; Bochem J; Spreuer J; Ottmann S; Martens A; Amaral T; Wagner NB; Claassen M; Meier F; Terheyden P; Garbe C; Eigentler T; Weide B; Pawelec G; Wistuba-Hamprecht K
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37286306
[TBL] [Abstract][Full Text] [Related]
9. Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study.
Mandruzzato S; Brandau S; Britten CM; Bronte V; Damuzzo V; Gouttefangeas C; Maurer D; Ottensmeier C; van der Burg SH; Welters MJ; Walter S
Cancer Immunol Immunother; 2016 Feb; 65(2):161-9. PubMed ID: 26728481
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer.
Goedegebuure P; Mitchem JB; Porembka MR; Tan MC; Belt BA; Wang-Gillam A; Gillanders WE; Hawkins WG; Linehan DC
Curr Cancer Drug Targets; 2011 Jul; 11(6):734-51. PubMed ID: 21599634
[TBL] [Abstract][Full Text] [Related]
11. Complexity and challenges in defining myeloid-derived suppressor cells.
Damuzzo V; Pinton L; Desantis G; Solito S; Marigo I; Bronte V; Mandruzzato S
Cytometry B Clin Cytom; 2015 Mar; 88(2):77-91. PubMed ID: 25504825
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of circulating myeloid-derived suppressor cell subsets: predicting poor clinical efficacy and prognosis through T cell suppression in non-Hodgkin's lymphoma.
Pu LF; Li MM; Feng XJ; Zhang T; Hu LH; Zheng HM; Charwudzi A; Ding YY; Liu J; Liu ZL; Xiong SD
J Leukoc Biol; 2024 May; 115(6):1094-1107. PubMed ID: 38369808
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of peripheral blood CD11b
Latifi A; Ghanizadeh-Vesali S; Hosseini S; Mohsenzadegan M
Med J Islam Repub Iran; 2020; 34():92. PubMed ID: 33315975
[No Abstract] [Full Text] [Related]
14. Circulating immunophenotypes are potentially prognostic in follicular cell-derived thyroid cancer.
Kotwal A; Gustafson MP; Bornschlegl S; Dietz AB; Delivanis D; Ryder M
Front Immunol; 2023; 14():1325343. PubMed ID: 38235146
[TBL] [Abstract][Full Text] [Related]
15. Evaluating Leukocyte Telomere Length and Myeloid-Derived Suppressor Cells as Biomarkers for Prostate Cancer.
Wakita H; Lu Y; Li X; Kobayashi T; Hachiya T; Ide H; Horie S
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611064
[TBL] [Abstract][Full Text] [Related]
16. Emerging Roles of Myeloid-Derived Suppressor Cells in Diabetes.
Wang S; Tan Q; Hou Y; Dou H
Front Pharmacol; 2021; 12():798320. PubMed ID: 34975496
[TBL] [Abstract][Full Text] [Related]
17. Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer.
Yamauchi Y; Safi S; Blattner C; Rathinasamy A; Umansky L; Juenger S; Warth A; Eichhorn M; Muley T; Herth FJF; Dienemann H; Platten M; Beckhove P; Utikal J; Hoffmann H; Umansky V
Am J Respir Crit Care Med; 2018 Sep; 198(6):777-787. PubMed ID: 29617574
[TBL] [Abstract][Full Text] [Related]
18. PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients: Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer.
Resch I; Shariat SF; Gust KM
Memo; 2018; 11(1):43-46. PubMed ID: 29606979
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
Li F; Zhao Y; Wei L; Li S; Liu J
Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
[TBL] [Abstract][Full Text] [Related]
20. Emerging Role of Immunotherapy in Advanced Urothelial Carcinoma.
Koshkin VS; Grivas P
Curr Oncol Rep; 2018 Apr; 20(6):48. PubMed ID: 29644490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
